Here is a Group of articles from the WSJ that are accessible on GLP-1’s as the ultimate anti-aging drug. Ozempic just approved for kidney disease, heart disease as well as diabetes regardless of weight loss. Cancer and many more to come. Many articles on GLP-1’s including one’s in the trial pipeline. I get WSJ electronic subscription for 50 cents week. This link is a gift for all. If you sign up for free WSJ Newsletter in the article you will have access to all the other articles listed. WSJ and NY Times are some of few newspapers left that have the money to research articles of interest.
https://www.wsj.com/health/wellness/ozempic-weight-loss-drug-aging-health-benefits-d93a22f8?st=ESS6aa&reflink=desktopwebshare_permalink
5 Likes
